Biological
Bone marrow-derived mesenchymal stem cells
Bone marrow-derived mesenchymal stem cells is a biological therapy with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Terminated(1)
Other(2)
Detailed Status
unknown2
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
withdrawn125%
recruiting125%
unknown250%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_1
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
NCT05095532
withdrawnphase_1
Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke
NCT01849887
unknownphase_1
Effect of BM-MSCs in DCD Kidney Transplantation
NCT02561767
unknownphase_1
Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs
NCT02327832
Clinical Trials (4)
Showing 4 of 4 trials
NCT05095532Phase 1
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
NCT01849887Phase 1
Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke
NCT02561767Phase 1
Effect of BM-MSCs in DCD Kidney Transplantation
NCT02327832Phase 1
Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4